$BIIB Headlines Cal-Maine Foods shares fall on earnings

New Post Public Reply Private Reply Replies (0) Message Board

Dec 24, 2014 at 1:11 PM

$BIIB Headlines

Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
Biogen Idec jumps 7%, faring best in S&P 500 9:33 a.m. Dec. 2, 2014 - Victor Reklaitis
Biogen's stock surges on upbeat outlook for Alzheimer's treatment 9:27 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen planning 'aggressively' to start Phase 3 study for Alzheimer's treatment 9:18 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen's stock rallies 5% in premarket trade 8:54 a.m. Dec. 2, 2014 - Tomi Kilgore
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore

How Gilead And Johnson & Johnson's Tumble Could've Burned These Hedge Funds 10:27 a.m. Today - benzinga.com
Stock Market News for December 24, 2014 - Market News 10:10 a.m. Today - Zacks.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Today - Zacks.com
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Today - Seeking Alpha
RBC’s 5 Top Biotech Stocks to Buy for 2015 9:07 a.m. Dec. 23, 2014 - 247WallSt.com
3 Best T. Rowe Price Funds for 2015 5:12 a.m. Dec. 23, 2014 - InvestorPlace.com
Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog 6:10 p.m. Dec. 22, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Express Scripts Picks AbbVie HCV Drugs Over Gilead 4:59 p.m. Dec. 22, 2014 - Investors Business Daily
Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog 4:55 p.m. Dec. 22, 2014 - Zacks.com
Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog 3:20 p.m. Dec. 22, 2014 - Zacks.com
Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog 3:10 p.m. Dec. 22, 2014 - Zacks.com
Eli Lilly-Adocia Strike Deal to Develop Ultra-Rapid Insulin - Analyst Blog 2:50 p.m. Dec. 22, 2014 - Zacks.com
Roche Loses A Little Luster Before Year-End 2:45 p.m. Dec. 22, 2014 - Seeking Alpha
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More 1:37 p.m. Dec. 22, 2014 - TheStreet.com
Puma Biotechnology (PBYI) Jumps: Stock Moves 6.1% Up - Tale of the Tape 9:39 a.m. Dec. 22, 2014 - Zacks.com
Morning Market Losers 9:01 a.m. Dec. 22, 2014 - benzinga.com
Prothena Corp. (PRTA) Looks Good: Stock Moves Up 5.7% - Tale of the Tape 8:51 a.m. Dec. 22, 2014 - Zacks.com
Benzinga's Top #PreMarket Losers 7:18 a.m. Dec. 22, 2014 - benzinga.com
Trade of the Day: IBB Up 40% YTD – Buy, Sell or Hold? 7:17 p.m. Dec. 21, 2014 - InvestorPlace.com

Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015 4:01 p.m. Dec. 23, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference 4:01 p.m. Dec. 22, 2014 - BusinessWire - BZX
Alnylam Elects Michael W. Bonney to Its Board of Directors 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Small Cap Profiles: OPXA, NEWC, TRNS, MLER 10:35 a.m. Dec. 11, 2014 - ACCESSWIRE
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kyndryl Targets Talent: Equity Awards for New Hires

Kyndryl's Strategic Play with Inducement Awards Today's hot ticket is Kyndryl (NYSE: KD) splashing around some inducement equity awards to reel in new recruits. A massive player in enterprise technology services, Kyndryl isn't just resting on its laurels. They're hunting fresh talent and flashing stock like currency. Welcome to 2026, where stocks aren’t just for Wall...

Better's 90-Day Plan: Growth Amidst Governance Gamble

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Graphic Packaging Names Berardinelli as HR Executive

A New Chapter in HR Leadership at Graphic Packaging September 8 marks a turning point for Graphic Packaging Holding Company with the appointment of Tatiana Berardinelli as their new Chief Human Resources Officer. As NYSE:GPK positions itself for ambitious growth, Berardinelli stands out for her knack for managing transformations and building cultures that thrive in...

Potassium Fluoride Market Growth Sparks Interest

Here's a story you might not have expected—potassium fluoride is finding its spotlight! With the market projected to tick upwards from USD 0.43 billion in 2026 to USD 0.51 billion by 2032, there's more here than meets the eye. A steady CAGR of 2.9% might not scream excitement, but steady growth often does the trick in chemicals. Why the Buzz Around Potassium Fluoride?...

USSM and IonicRE Partner to Enhance US Rare Earths Supply

Sometimes, it's not just about playing the game, but knowing which card to play. US Strategic Metals (USSM) and Ionic Rare Earths USA just unveiled a strategic move that’s likely to shake things up in the wild world of rare earths. As the partnership gears up to build a magnet recycling facility in Missouri, there’s chatter around creating a sustainable supply chain...

Mental Health Lab Aims to Boost Workforce Resilience

Redefining Workforce Mental Health It’s about time someone shook up how we tackle workforce mental health. Enter Project Healthy Minds and their newly minted Workforce Lab, roping in some of the big dogs like Acast, KPMG, and L'Oréal USA. They've tagged Harvard Business School gurus to churn out data on what helps—or harms—workplace sanity. Finally, a chance to put...

Hydrogen Mobility Gains Steam: Industry & Policy Unite

The winds are changing, and this time, it's hydrogen that's blowing into town. Europe may just be on the brink of a major trucking overhaul, driven by a concoction of industry giants and supportive policies. The stage is set for hydrogen trucks to roll out by 2030, aiming to gut traditional fuel options and stack the odds in favor of zero-emission transport. Can you smell...

Exploring Before and After School Care Dynamics in PA

Navigating the World of Before and After School Care The dad juggling a morning coffee and a laptop at a crowded diner—he’s not just browsing social media; he's flipping through options for his kid’s care. In Harrisburg, PA, before and after school care isn't just babysitting, it’s a lifeline for working parents balancing the chaos of modern schedules. Timothy R....

Rodeo Dental Gears Up for National Growth Surge

Rodeo Dental's Leadership Shuffle When you're talking about upping the ante in the dental world, you can't ignore the recent shake-up at Rodeo Dental & Orthodontics. They've decided to retool their corner office lineup, and this is where the folks in suits meet the folks with the steady hands in teeth. Co-Founder Dr. Saam Zarrabi is stepping into an Executive Chairman...

ECRI Welcomes Safety Expert Meshkati to Its Board

The Safety Maverick Steps into Healthcare They've gone and done it—appointed a rockstar of systems safety to ECRI's Board of Trustees. Professor Najmedin Meshkati, who's practically been around every major industrial accident of the past few decades, is about to shake things up. Imagine the guy who's dissected calamities like the BP Texas City Refinery explosion and the...